Pediatric Epilepsy Therapeutics Market By Disease Type, Therapeutics and End User - Global Industry Analysis & Forecast to 2025

Published On : October 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC101454

Pediatric Epilepsy Therapeutics Market By Disease Type (Childhood absence epilepsy (CAE), Infantile spasms (or West syndrome), Benign rolandic epilepsy (BRE), Juvenile myoclonic epilepsy (JME), Lennox-gastaut syndrome (LGS) and Others) Therapeutics (Dietary supplements, Surgical therapies, Anti-epileptic drugs and Vagal nerve stimulation) End User (Neurology Centers, Ambulatory Surgical Centers, Hospitals, Home care settings) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Pediatric Epilepsy Therapeutics Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Epilepsy is an incessant neurological disorder that prompts repetitive seizures, described by brief and imperceptible scenes of automatic development including either a body part or the whole body. The main reason for epilepsy is obscure notwithstanding, a few people develop epilepsy as the aftereffect of strokes, trauma, infections, brain tumor and birth complications. As indicated by World Health Organization (WHO), around 50 million of total populace is as of now dealing with epilepsy making it a standout amongst the most well-known neurological disorder around the world. The ailment is observed to be pervasive in pediatric populace in comparison to the adult populace prompting more prominent likelihood for general specialists to counsel patients with epilepsy on a daily basis.

Drivers and Restraints

Constant rise in different neurological issues among youngsters' is the essential factor contributing towards development of pediatric epilepsy therapeutics market over the figure time frame. Additionally developing endeavors to build up AED's with novel component of activity is foreseen to enhance the pattern of treatment. Rising prevalence of various neurological problems have brought about interest in extensive research and development to introduce novel treatments for pediatric epilepsy treatment. 

Regional Insights

North America is the dominant region of the market and is anticipated to continue leading the market over the forecast period. Asia Pacific is anticipated to develop substantially.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Novartis
  • Pfizer
  • Bausch Health
  • Johnson & Johnson
  • Cephalon, Inc.
  • GlaxoSmithKline
  • Sanofi
  • Sunovion
  • Abbott Laboratories

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Pediatric Epilepsy Therapeutics Market, By Disease Type, Estimates and Forecast, 2014-2025($Billion)

o    Childhood absence epilepsy (CAE)

o    Infantile spasms (or West syndrome)

o    Benign rolandic epilepsy (BRE)

o    Juvenile myoclonic epilepsy (JME)

o    Lennox-gastaut syndrome (LGS)

o    Others

·         Pediatric Epilepsy Therapeutics Market, By Therapeutics, Estimates and Forecast, 2014-2025($Billion)

o    Dietary supplements

o    Surgical therapies

o    Anti-epileptic drugs

o    Vagal nerve stimulation

·         Pediatric Epilepsy Therapeutics Market, By End User, Estimates and Forecast, 2014-2025($Billion)

o    Neurology Centers

o    Ambulatory Surgical Centers

o    Hospitals

o    Home care settings

·         Pediatric Epilepsy Therapeutics Market, By Region, Estimates and Forecast, 2014-2025($Billion)

o    North America

§  North America Pediatric Epilepsy Therapeutics Market, By Country

o    U.S. Pediatric Epilepsy Therapeutics Market

o    Canada Pediatric Epilepsy Therapeutics Market

o    Mexico Pediatric Epilepsy Therapeutics Market

o    Europe

§  Europe Pediatric Epilepsy Therapeutics Market, By Country

o    Germany Pediatric Epilepsy Therapeutics Market

o    UK Pediatric Epilepsy Therapeutics Market

o    France Pediatric Epilepsy Therapeutics Market

o    Russia Pediatric Epilepsy Therapeutics Market

o    Italy Pediatric Epilepsy Therapeutics Market

o    Rest of Europe Pediatric Epilepsy Therapeutics Market

o    Asia-Pacific

§  Asia-Pacific Pediatric Epilepsy Therapeutics Market, By Country

o    China Pediatric Epilepsy Therapeutics Market

o    Japan Pediatric Epilepsy Therapeutics Market

o    South Korea Pediatric Epilepsy Therapeutics Market

o    India Pediatric Epilepsy Therapeutics Market

o    Southeast Asia Pediatric Epilepsy Therapeutics Market

o    Rest of Asia-Pacific Pediatric Epilepsy Therapeutics Market

o    South America

§  South America Pediatric Epilepsy Therapeutics Market

o    Brazil Pediatric Epilepsy Therapeutics Market

o    Argentina Pediatric Epilepsy Therapeutics Market

o    Columbia Pediatric Epilepsy Therapeutics Market

o    Rest of South America Pediatric Epilepsy Therapeutics Market

o    Middle East and Africa

§  Middle East and Africa Pediatric Epilepsy Therapeutics Market

o    Saudi Arabia Pediatric Epilepsy Therapeutics Market

o    UAE Pediatric Epilepsy Therapeutics Market

o    Egypt Pediatric Epilepsy Therapeutics Market

o    Nigeria Pediatric Epilepsy Therapeutics Market

o    South Africa Pediatric Epilepsy Therapeutics Market

o    Rest of MEA Pediatric Epilepsy Therapeutics Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Pediatric Epilepsy Therapeutics Market, By Disease Type

5.1.     Introduction

5.2.     Global Pediatric Epilepsy Therapeutics Revenue and Market Share by Disease Type (2014-2018)

5.2.1.  Global Pediatric Epilepsy Therapeutics Revenue and Revenue Share by Disease Type (2014-2018)

5.3.     Childhood absence epilepsy (CAE)

5.3.1.  Global Childhood absence epilepsy (CAE) Revenue and Growth Rate (2014-2018)

5.4.     Infantile spasms (or West syndrome)

5.4.1.  Global Infantile spasms (or West syndrome) Revenue and Growth Rate (2014-2018)

5.5.     Benign rolandic epilepsy (BRE)

5.5.1.  Global Benign rolandic epilepsy (BRE) Revenue and Growth Rate (2014-2018)

5.6.     Juvenile myoclonic epilepsy (JME)

5.6.1.  Global Juvenile myoclonic epilepsy (JME) Revenue and Growth Rate (2014-2018)

5.7.     Lennox-gastaut syndrome (LGS)

5.7.1.  Global Lennox-gastaut syndrome (LGS) Revenue and Growth Rate (2014-2018)

5.8.     Others

5.8.1.  Global Others Revenue and Growth Rate (2014-2018)

6.       Pediatric Epilepsy Therapeutics Market, By Therapeutics

6.1.     Introduction

6.2.     Global Pediatric Epilepsy Therapeutics Revenue and Market Share by Therapeutics (2014-2018)

6.2.1.  Global Pediatric Epilepsy Therapeutics Revenue and Revenue Share by Therapeutics (2014-2018)

6.3.     Dietary supplements

6.3.1.  Global Dietary supplements Revenue and Growth Rate (2014-2018)

6.4.     Surgical therapies

6.4.1.  Global Surgical therapies Revenue and Growth Rate (2014-2018)

6.5.     Anti-epileptic drugs

6.5.1.  Global Anti-epileptic drugs Revenue and Growth Rate (2014-2018)

6.6.     Vagal nerve stimulation

6.6.1.  Global Vagal nerve stimulation Revenue and Growth Rate (2014-2018)

7.       Pediatric Epilepsy Therapeutics Market, By End User

7.1.     Introduction

7.2.     Global Pediatric Epilepsy Therapeutics Revenue and Market Share by End User (2014-2018)

7.2.1.  Global Pediatric Epilepsy Therapeutics Revenue and Revenue Share by End User (2014-2018)

7.3.     Neurology Centers

7.3.1.  Global Neurology Centers Revenue and Growth Rate (2014-2018)

7.4.     Ambulatory Surgical Centers

7.4.1.  Global Ambulatory Surgical Centers Revenue and Growth Rate (2014-2018)

7.5.     Hospitals

7.5.1.  Global Hospitals Revenue and Growth Rate (2014-2018)

7.6.     Home care settings

7.6.1.  Global Home care settings Revenue and Growth Rate (2014-2018)

8.       Pediatric Epilepsy Therapeutics Market, By Region

8.1.     Introduction

8.2.     Global Pediatric Epilepsy Therapeutics Revenue and Market Share by Regions

8.2.1.  Global Pediatric Epilepsy Therapeutics Revenue by Regions (2014-2018)

8.3.     North America Pediatric Epilepsy Therapeutics by Countries

8.3.1.  North America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

8.3.2.  North America Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Pediatric Epilepsy Therapeutics by Countries

8.4.1.  Europe Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Pediatric Epilepsy Therapeutics by Countries

8.5.1.  Asia-Pacific Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Pediatric Epilepsy Therapeutics by Countries

8.6.1.  South America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

8.6.2.  South America Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Pediatric Epilepsy Therapeutics by Countries

8.7.1.  Middle East and Africa Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Novartis

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Pfizer

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     Bausch Health

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Johnson & Johnson

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Cephalon, Inc.

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     GlaxoSmithKline

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Sanofi

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     Sunovion

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Abbott Laboratories

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

10.    Global Pediatric Epilepsy Therapeutics Market Competition, by Manufacturer

10.1. Global Pediatric Epilepsy Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Pediatric Epilepsy Therapeutics Price By Region (2016-2017)

10.3. Top 5 Pediatric Epilepsy Therapeutics Manufacturer Market Share

10.4. Market Competition Trend

11.    Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.1. Global Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Pediatric Epilepsy Therapeutics Market Forecast by Regions (2018-2025)

11.2.1.      North America Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.1.1. United States Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.1.2. Canada Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.1.3. Mexico Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.2.      Europe Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.2.1. Germany Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.2.2. France Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.2.3. UK Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.2.4. Russia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.2.5. Italy Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.3.      Asia-Pacific Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.3.1. China Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.3.2. Japan Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.3.3. Korea Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.3.4. India Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.4.      South America Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.4.1. Brazil Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.4.2. Argentina Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.4.3. Columbia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.4.4. Rest of South America Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.      Middle East and Africa Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.3. Egypt Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.4. Nigeria Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.5. South Africa Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.6. Turkey Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

11.3. Pediatric Epilepsy Therapeutics Market Forecast by Disease Type (2018-2025)

11.3.1.      Pediatric Epilepsy Therapeutics Forecast by Disease Type (2018-2025)

11.3.2.      Pediatric Epilepsy Therapeutics Market Share Forecast by Disease Type (2018-2025)

11.4. Pediatric Epilepsy Therapeutics Market Forecast by Therapeutics (2018-2025)

11.4.1.      Pediatric Epilepsy Therapeutics Forecast by Therapeutics (2018-2025)

11.4.2.      Pediatric Epilepsy Therapeutics Market Share Forecast by Therapeutics (2018-2025)

11.5. Pediatric Epilepsy Therapeutics Market Forecast by End User (2018-2025)

11.5.1.      Pediatric Epilepsy Therapeutics Forecast by End User (2018-2025)

11.5.2.      Pediatric Epilepsy Therapeutics Market Share Forecast by End User (2018-2025)


List of Tables

List of Tables and Figures

Figure United States Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Canada Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Mexico Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Germany Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure France Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure UK Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Russia Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Italy Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Europe Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure China Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Japan Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Korea Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure India Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Southeast Asia Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Asia-Pacific Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Brazil Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Argentina Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Columbia Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of South America Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Saudi Arabia Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure United Arab Emirates Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Egypt Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Nigeria Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure South Africa Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Turkey Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Middle East and Africa Pediatric Epilepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)

Table Global Pediatric Epilepsy Therapeutics Revenue and Revenue Share by Disease Type (2014-2018)

Figure Global Childhood absence epilepsy (CAE) Revenue and Growth Rate (2014-2018)

Figure Global Infantile spasms (or West syndrome) Revenue and Growth Rate (2014-2018)

Figure Global Benign rolandic epilepsy (BRE) Revenue and Growth Rate (2014-2018)

Figure Global Juvenile myoclonic epilepsy (JME) Revenue and Growth Rate (2014-2018)

Figure Global Lennox-gastaut syndrome (LGS) Revenue and Growth Rate (2014-2018)

Figure Global Others Revenue and Growth Rate (2014-2018)

Table Global Pediatric Epilepsy Therapeutics Revenue and Revenue Share by Therapeutics (2014-2018)

Figure Global Dietary supplements Revenue and Growth Rate (2014-2018)

Figure Global Surgical therapies Revenue and Growth Rate (2014-2018)

Figure Global Anti-epileptic drugs Revenue and Growth Rate (2014-2018)

Figure Global Vagal nerve stimulation Revenue and Growth Rate (2014-2018)

Table Global Pediatric Epilepsy Therapeutics Revenue and Revenue Share by End User (2014-2018)

Figure Global Neurology Centers Revenue and Growth Rate (2014-2018)

Figure Global Ambulatory Surgical Centers Revenue and Growth Rate (2014-2018)

Figure Global Hospitals Revenue and Growth Rate (2014-2018)

Figure Global Home care settings Revenue and Growth Rate (2014-2018)

Table Global Pediatric Epilepsy Therapeutics Revenue by Regions (2014-2018)

Figure North America Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure North America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

Figure North America Pediatric Epilepsy Therapeutics by Countries (2014-2018)

Figure North America Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

Figure United States Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure United States Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Canada Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Canada Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Mexico Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Mexico Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Europe Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Europe Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

Figure Europe Pediatric Epilepsy Therapeutics by Countries (2014-2018)

Figure Europe Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

Figure Germany Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Germany Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure France Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure France Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure UK Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure UK Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Russia Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Russia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Italy Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Italy Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Europe Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Rest of Europe Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Asia-Pacific Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Asia-Pacific Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

Figure Asia-Pacific Pediatric Epilepsy Therapeutics by Countries (2014-2018)

Figure Asia-Pacific Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

Figure China Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure China Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Japan Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Japan Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Korea Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Korea Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure India Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure India Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Southeast Asia Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Southeast Asia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South America Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure South America Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

Figure South America Pediatric Epilepsy Therapeutics by Countries (2014-2018)

Figure South America Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

Figure Brazil Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Brazil Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Argentina Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Argentina Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Columbia Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Columbia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of South America Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Rest of South America Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Middle East and Africa Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Middle East and Africa Pediatric Epilepsy Therapeutics Revenue and Growth Rate (2014-2018)

Figure Middle East and Africa Pediatric Epilepsy Therapeutics by Countries (2014-2018)

Figure Middle East and Africa Pediatric Epilepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

Figure Saudi Arabia Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Saudi Arabia Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure United Arab Emirates Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure United Arab Emirates Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Egypt Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Egypt Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Nigeria Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Nigeria Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South Africa Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure South Africa Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Turkey Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Turkey Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Pediatric Epilepsy Therapeutics Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

Table Novartis Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bausch Health Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Cephalon, Inc. Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sunovion Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Laboratories Pediatric Epilepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Pediatric Epilepsy Therapeutics Market Share by Manufacturer

Figure Global Pediatric Epilepsy Therapeutics Revenue and Market Share by Manufacturer

Table Global Pediatric Epilepsy Therapeutics Price by Region (2016-2017)

Figure Top 5 Pediatric Epilepsy Therapeutics Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Pediatric Epilepsy Therapeutics Revenue (Millions USD) and Growth Rate (2018-2025)

Table Pediatric Epilepsy Therapeutics Market Forecast by Regions (2018-2025)

Figure North America Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure United States Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Canada Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Mexico Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Europe Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Germany Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure France Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure UK Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Russia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Italy Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Rest of Europe Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Asia-Pacific Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure China Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Japan Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Korea Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure India Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Southeast Asia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure South America Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Brazil Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Argentina Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Columbia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Rest of South America Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Middle East and Africa Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Saudi Arabia Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure United Arab Emirates Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Egypt Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Nigeria Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure South Africa Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Turkey Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Pediatric Epilepsy Therapeutics Market Forecast (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Forecast by Disease Type (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Market Share Forecast by Disease Type (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Forecast by Disease Type (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Forecast by Therapeutics (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Market Share Forecast by Therapeutics (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Forecast by Therapeutics (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Forecast by End User (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Market Share Forecast by End User (2018-2025)

Figure Global Pediatric Epilepsy Therapeutics Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*